Jump to content
  • Our Mission Pooling competencies – pushing innovations

    BIOPRO Baden-Württemberg GmbH supports the medical technology, biotechnology and pharmaceutical sectors in the healthcare industry as well as the development of a bioeconomy in Baden-Württemberg.

  • Healthcare industry BW Industry report

    We track the economic performance of companies actively engaged in biotechnology, medical technology and pharmaceutical industry. Our publications provide the latest facts und figures for Baden-Württemberg’s healthcare industry.

  • Bioeconomy BW Towards greater sustainability

    We support regional bioeconomic strategies to promote and strengthen sustainability objectives in Baden-Württemberg. These strategies include regional research and development capacities, analyse approaches for circular economy and aim at the establishment of interfaces to both internal and external partners.

Latest news

Register now!

Online
Registration deadline:

Focusing on novel therapeutic and diagnostic immunological approaches to fight cancer, our 18. joint event with BioValley France will take place on the 3rd of December, 2020 in Strasbourg. Register now and apply for a short presentation!

The bioeconomy and the healthcare sector are seen as strategically important future sectors in the EU's Strategy for the Alpine Region. BIOPRO Baden-Württemberg GmbH is the lead partner in the EU-cofinanced ARDIA-Net project, which got underway in October 2019. The aim of the project is to develop a transnational funding programme for research, development and innovation (R&I) for regional and local authorities in the Alpine macroregion. Baden-Württemberg has a lot to offer for founders and start-ups. The entire diversity of Baden-Württemberg's start-up landscape will be on display at the Start-up BW Summit on July 23 and 24, 2020.


New on ...

... Healthcare industry in BW

When the liver stops regenerating on its own, it might be possible in future for doctors to intervene with a chemical agent. Tübingen-based HepaRegeniX GmbH is developing a promising candidate with the aim of improving the treatment of both acute and chronic liver failure.

... Healthcare industry BW

The search for drug candidates for COVID-19 diseases is well underway. Factor H, which is part of the innate immune system, might also be a future therapeutic option. The Freiburg-based biotech company eleva has developed a technology for producing this human protein in moss cells. The active ingredient, which might also have a regulatory effect in other diseases, is currently undergoing preclinical testing.

... Healthcare industry BW

Anyone who thinks hemp is just an inconspicuous plant, whose ingredients can be used, at best, as an intoxicant, can quickly be proven wrong. Besides being used as a valuable raw material for textiles and building materials, the plant has great potential as a medicinal drug. The CANNABIS-NET network, coordinated by the University of Hohenheim, has been set up to establish the basis for producing medicinal hemp in Germany.

... Bioeconomy in BW

Recycled material instead of waste: wood ash is good for soil and plants - if the quality is right. The German Federal Quality Association for Food Ash ensures reliable wood ash standards with its certifications. The RAL-Dünger label for fertilisers provides the necessary certification for natural wood ashes to be used in the circular economy.

... Bioeconomy in BW

In Germany alone, around three billion disposable coffee capsules made of aluminium and plastic are sold every year. This creates a gigantic waste problem, as only a small proportion of the capsules can be recycled. Fully compostable wooden coffee capsules that are compatible with all standard Nespresso® machines might be a solution to this problem. The capsules have been developed by a start-up company called rezemo, which also has other biobased packaging solutions in the pipeline.

Website address: https://www.bio-pro.de/en